By Buy This GLP Editorial Team · Editorial profile: Wesley Jenkins
FORM review
Separate brand access fees
FORM by GBY lists branded access memberships and compounded programs. A clinician reviews whether treatment is appropriate.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
FORM by GBY lists a $95 monthly access membership for branded Wegovy tablets and Zepbound injections. The two pages direct eligible patients to NovoCare Pharmacy and LillyDirect, respectively.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at FORM
- Cancellation
- The branded pages say membership can be canceled at any time. Confirm how canceling affects a prescription or payment already in process.
Pricing transparency
How FORM publishes its prices
Add the pharmacy’s medication charge to the membership fee when comparing costs. LifeMD separates its care fee from drug costs too, so use the same dose and pharmacy price when you compare these two memberships. FORM’s branded pages do not establish that pharmacy charge. Its public compounded injection pages do not publish a comparable price.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What FORM is
FORM by GBY connects patients with a licensed provider online. It lists compounded injections and routes to branded medications.
How it works
FORM describes a provider review before an eligible patient can use a branded pharmacy route. Medication and access charges are separate.
Branded or compounded
Wegovy tablets and Zepbound injections are branded medicines. FORM also lists compounded semaglutide and tirzepatide injections, which do not receive FDA approval or premarket review.
Where the money holds, and where it moves
Predictable
- Publishes key billing information
Moves, or is not stated
- Final charges depend on the selected prescription and plan
Who this is worth it for
Someone comparing clinician support for a branded prescription through a manufacturer pharmacy.
Who should price elsewhere
Someone looking for one public price for both medication and ongoing care.
The molecules
What FORM prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside FORM
MEDViBuyers who can confirm the first charge and refill schedule on the same offer
See MEDVi →
Kin MedsPeople comparing clinician access and who can confirm medication charges before ordering.
See Kin Meds →
CollectivePatients expecting sustained treatment who can use the membership year
See Collective →
More GLP-1 telehealth sellers priced end to end: Tyde WellnessUR MedsValhalla VitalityVaylenVelvet RxVevaRX
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Where should I confirm the final charge?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare FORM against every seller on it.